Inc. Aventis serves as Executive at INTROGEN THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Inc. Aventis has executed 11 insider transactions totaling $1.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 6, 2006 involved selling 20,439 shares valued at $82.6K.
Inc. Aventis currently holds 3,724,002 shares of INTROGEN THERAPEUTICS INC (INGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Inc. Aventis has been a net seller of INGN stock. They have purchased $0 and sold $1.3M worth of shares.
Inc. Aventis's most recent insider trade was on Sep 6, 2006, when they sold 20,439 shares at $4.04 per share.
Get notified when new Form 4 filings are submitted
| $3.99 |
| Discretionary |
| Sep 1, 2006 | INGN | $79.2K | Sale | 20,100 | $3.94 | Discretionary |
| Aug 31, 2006 | INGN | $132.8K | Sale | 33,530 | $3.96 | Discretionary |
| Aug 16, 2006 | INGN | $159.2K | Sale | 41,355 | $3.85 | Discretionary |
| Aug 15, 2006 | INGN | $82.7K | Sale | 21,212 | $3.90 | Discretionary |
| Aug 14, 2006 | INGN | $135.3K | Sale | 34,700 | $3.90 | Discretionary |
| Aug 11, 2006 | INGN | $117.3K | Sale | 30,000 | $3.91 | Discretionary |
| Apr 4, 2006 | INGN | $356.9K | Sale | 65,845 | $5.42 | Discretionary |
| Mar 28, 2006 | INGN | $50.6K | Sale | 9,526 | $5.31 | Discretionary |
| Mar 20, 2006 | INGN | $66.9K | Sale | 12,599 | $5.31 | Discretionary |